Corcept Therapeutics' net profit under GAAP for 6 months of 2020 was $58,392 million, up 51.8% from $38.46 million in the previous year. Revenue increased by 32.6% to $181,812 million from $137,086 million a year earlier.
Corcept Therapeutics' net profit under GAAP for 6 months of 2020 was $58,392 million, up 51.8% from $38.46 million in the previous year. Revenue increased by 32.6% to $181,812 million from $137,086 million a year earlier. 
ir.corcept.com
English (US) 